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Objectives This study aimed to test the hypothesis that metabolic activity within periodontal tissue (a possible surrogate for peri-
odontal inflammation) predicts inflammation in a remote atherosclerotic vessel, utilizing 18F-fluorodeoxyglucose
(FDG) positron emission tomography (PET) imaging.
Background Several lines of evidence establish periodontal disease as an important risk factor for atherosclerosis. FDG-PET
imaging is an established method for measuring metabolic activity in human tissues and blood vessels.
Methods One hundred twelve patients underwent FDG-PET imaging 92  5 min after FDG administration (13 to 25 mCi).
Periodontal FDG uptake was measured by obtaining standardized uptake values from the periodontal tissue of
each patient, and the ratio of periodontal to background (blood) activity was determined (TBR). Standardized up-
take value measurements were obtained in the carotid and aorta as well as in a venous structure. Localization of
periodontal, carotid, and aortic activity was facilitated by PET coregistration with computed tomography or magnetic
resonance imaging. A subset of 16 patients underwent carotid endarterectomy within 1 month of PET imaging, dur-
ing which atherosclerotic plaques were removed and subsequently stained with anti-CD68 antibodies to quantify mac-
rophage infiltration. Periodontal FDG uptake was compared with carotid plaque macrophage infiltration.
Results Periodontal FDG uptake (TBR) is associated with carotid TBR (R  0.64, p  0.0001), as well as aortic TBR (R 
0.38; p  0.029). Moreover, a strong relationship was observed between periodontal TBR and histologically as-
sessed inflammation within excised carotid artery plaques (R  0.81, p  0.001).
Conclusions FDG-PET measurements of metabolic activity within periodontal tissue correlate with macrophage infiltration
within carotid plaques. These findings provide direct evidence for an association between periodontal disease
and atherosclerotic inflammation. (J Am Coll Cardiol 2011;57:971–6) © 2011 by the American College of
Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.09.056t
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rPeriodontal disease (PD), which affects approximately 40%
of U.S. adults (1), has a well-documented association with
atherosclerosis (2–11). Laboratory evidence and findings
from both clinical and epidemiological studies suggest
existence of a biological association between PD and car-
diovascular disease (CVD) (2,10,12). PD has been reported
to be an independent risk factor of CVD and stroke
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2010, accepted September 27, 2010.(12–15). Because inflammation plays an important role in
the pathophysiology of both periodontal disease and ath-
erosclerosis (16–19), we investigated the relationship be-
tween 18F-fluorodeoxyglucose (FDG) uptake in periodontal
issue (a nuclear imaging marker of inflammation) and
DG uptake in atherosclerotic plaques within the carotid
rteries and aorta.
Positron emission tomography (PET) imaging has been
hown to be an important imaging technique for the
dentification of metabolically active regions such as tumors
20,21) and inflammatory foci (22,23). The PET signal
erives substantially from FDG accumulation within the mac-
ophages (11,24,25). Our group and others have previously
emonstrated that FDG uptake in the carotid arteries corre-
m
t
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flammation (25). Several studies
have shown FDG-PET imaging
to improve the diagnosis and eval-
uation of oral lesions (26,27). Ac-
cordingly, we tested the hypothesis
that periodontal FDG uptake cor-
relates with FDG uptake in the
carotid arteries and FDG uptake
in the aorta as well as with histo-
logically determined inflammation
within atherosclerotic plaques.
Methods
Patients. One hundred twelve
patients were included in this
study. Patients were identified
from a database of patients who
had undergone FDG-PET imaging for evaluation of ath-
erosclerotic inflammation or for cancer screening. Patients
were excluded if they had a history of cancer within 2 years
of imaging. Additionally, all patients underwent either
computed tomography (CT) or magnetic resonance imag-
ing (MRI) for structural delineation of PET activity. A
subset of 16 patients with moderate to severe carotid artery
stenosis underwent carotid endarterectomy (CEA) within 1
month after PET imaging, after which their carotid plaque
specimens were available for analysis. Eligibility criteria for
these 16 patients included a 70% to 99% stenosis of the internal
carotid artery detected by carotid Doppler ultrasound, mag-
netic resonance angiography, or computerized tomography
angiography. The study protocol was approved by the local
Human Research Committee, and informed consent was
obtained from each subject.
Figure 1 FDG-PET Periodontal Measurement
Images from positron emission tomography (PET) and PET–computed tomography
The boxes within the PET-CT image delineate the region from which FDG activity is
ipsilateral aspect of the teeth (cheek side) in order to avoid inclusion of tongue ac
would be expected from metabolically active periodontal tissue.
Abbreviations
and Acronyms
CEA  carotid
endarterectomy
CT  computed
tomography
FDG 
18F-fluorodeoxyglucose
MRI  magnetic resonance
imaging
PD  periodontal disease
PET  positron emission
tomography
SUV  standardized uptake
value
TBR  target-to-
background ratioPET imaging. FDG was administered (14.4  0.4 mCi)
intravenously after an overnight fast. Imaging was per-
formed (92  5 min later) using a Siemens ECAT Exact
HR or comparable system, which provides 63 planes, a
15.5-cm field of view, and 4.2-mm intrinsic resolution. Data
were acquired in 3-dimensional mode over approximately 30
min. Attenuation-corrected images were reconstructed using a
Hanning filter with a conventional, filtered back-projection
algorithm yielding an effective resolution of 5 mm.
Anatomical imaging and image coregistration. To obtain
structural delineation of the carotid arteries and their
atherosclerotic plaques, anatomical imaging with either
multidetector computerized tomography or MRI was per-
formed using previously reported methods (28,29). The
PET images were coregistered with the structural (multi-
detector computerized tomography or MRI) images using a
workstation that enables multi-modal standard (rigid) im-
age fusion (Leonardo-TrueD, Siemens Solutions, Malvern,
Pennsylvania). The PET and CT (or MRI) images were
manually coregistered by an investigator blinded to the pa-
tients’ clinical history and histological analysis of CEA sam-
ples. Coregistration of PET and structural images was accom-
plished by evaluating extravascular anatomical landmarks (such
as periodontal, brain, spinal cord, spine, and jaw) that were
apparent on both images.
Measurement of FDG uptake in periodontal tissue. Af-
ter coregistration, periodontal tissues were first identified on
CT or MRI. Thereafter, the gums were divided into 4 sections:
upper right, upper left, lower right, and lower left. To limit
spillover from pharyngeal and buccal structures, analysis was
limited to the upper posterior gingival tissue (Fig. 1).
The maximum standardized uptake value (SUVmax) was
easured in each of the regions. SUV is the decay-corrected
issue concentration of FDG (in kilobecquerels per millili-
emonstrate 18F-fluorodeoxyglucose (FDG) activity localizing to periodontal tissues.
ured. Note that the boxes are drawn from the middle of the teeth toward the
The PET images emphasize the contouring of FDG activity around the teeth, as(CT) d
meas
tivity.
F
m
d
j
b
d
r
m
m
d
M
t
m
t
a
m
a
g
s
d
H
w
m
J
q
m
t

e
a
C
P
t
c
d
d
t
s
C
r
v
l
a
S
s
p
n
w
i
h
o
w
u
f
e
R
P
i
I
d
p
j
p
w
0
c
c
(
t
c
(
r
l
a
D
O
c
(
m
973JACC Vol. 57, No. 8, 2011 Fifer et al.
February 22, 2011:971–6 Periodontal FDG Uptake and Carotid Inflammationter) divided by the injected dose per body weight (kilobec-
querels per gram). To obtain a background value for FDG
uptake, SUV was measured in a venous structure (the
internal jugular vein for this analysis), in an area devoid of
significant spillover activity. Afterward, a target to back-
ground ratio (TBR) was calculated as periodontal tissue
SUV divided by venous blood SUV, and average TBRs were
calculated for each of the patients.
Measurement of FDG uptake in carotid tissue. Carotid
DG uptake was measured using previously described
ethods (25). TBR was calculated as carotid plaque SUV
ivided by venous blood SUV measured in the internal
ugular vein.
Blinding was maintained between investigators responsi-
le for the registration of PET and structural images and the
etermination of PET uptake, on the one hand, and those
esponsible for the histological analyses of the CEA speci-
ens, on the other. The reproducibility of PET measure-
ents of atherosclerotic plaque activity has been previously
escribed (30).
easurement of FDG uptake in aorta. After coregistra-
ion of the PET and CT or MRI images, FDG uptake was
easured along the ascending aorta. Measurements were
aken distal to the origin of the left main coronary artery to
void spillover activity from the myocardium. SUV was
easured in regions of interest that were drawn around the
ortic vessel wall in axial images at 5-mm intervals. Back-
round SUVs for the aortic analysis were measured in the
uperior vena cava. TBR was calculated as aortic SUV
ivided by venous SUV.
istology and immunohistochemistry. Plaque histology
as examined as described previously (25). Assessment of
acrophage staining was performed using the methods of
ander et al. (31). Computer-assisted planimetry was used to
uantify areas of staining. Total section areas and areas of
acrophage infiltration were outlined manually by comparing
he computerized image with the microscopic image at4 and
20 magnification. Macrophage staining was determined at
ach carotid slice and was reported as percentage of the plaque
rea staining for CD68-positive cells.
oregistration and comparison of histological and carotid
ET data. The axial PET images were registered to his-
ology sections on the basis of the distance from the
ommon carotid bifurcation. The carotid bifurcation was
efined as the apex of the luminal flow divider (which
ivides internal and external carotid artery), as identified on
he CT (or MRI) images as well as the pathological
pecimens. Contraction (due to axial elastic recoil) of the
EA specimen during histological processing (between its
elatively stretched state in vivo to a more contracted state ex
ivo) was observed. To account for this change in tissue
ength, 25% contraction in the length of the specimens
long the inferior-superior dimension was assumed.
tatistical methods. Data were analyzed using SAS ver-
ion 9.2 (SAS Institute, Cary, North Carolina). Continuousarameters are reported as the mean  SEM. Given
on-normal distribution of values, Spearman correlation
as used to assess the relationship between the FDG uptake
n periodontal tissue, the carotid, and aorta (TBR) and the
istopathological assessment of inflammation (percentage
f CD68 staining). Partial correlations (Spearman method)
ere used to assess the relationship between periodontal
ptake of FDG and vascular inflammation, while correcting
or potential confounders. A value of p  0.05 was consid-
red statistically significant.
esults
atient characteristics. Patient characteristics are displayed
n Table 1.
maging and histology. FDG uptake was qualitatively
iscernible in the periodontal tissues in a majority of
atients and appeared to be inhomogeneous in many sub-
ects (Fig. 1). The interobserver interclass coefficient for the
eriodontal SUV measurement was 0.77 (p  0.001).
The FDG uptake (TBR) in periodontal tissues correlated
ith carotid plaque TBR (R  0.64, p  0.0001) (Fig. 2).
This association remained significant after adjusting for age,
sex, low-density lipoprotein cholesterol, history of hyper-
tension, statin therapy, and diabetes (R  0.56, p 
.0001), as well as blood glucose concentration and tracer
irculation time (R  0.78, p  0.0001). A weaker
orrelation was found between periodontal and aortic TBR
R  0.38, p  0.029).
Moreover, periodontal TBR was strongly correlated with
he histologically determined inflammation observed in the
arotid plaque specimens by CD68 macrophage staining
R  0.81, p  0.001) (Figs. 3A and 3B). This association
emained significant after adjusting for age, sex, low-density
ipoprotein cholesterol, history of hypertension, statin ther-
py, and diabetes (R  0.56, p  0.0001).
iscussion
ur study demonstrates that periodontal metabolic activity
orrelates well with both FDG uptake in the carotid artery
an index of plaque inflammation) and histologically derived
easures of carotid plaque inflammation. Accordingly,
Patient CharacteristicsTable 1 Patient Characteristics
Age (yrs) 65.0 1.1
Male 65
Atherosclerosis 68
Diabetes 20
Smoking 29
Hypertension 62
LDL cholesterol (mg/dl) 85.9 4.0
HDL cholesterol (mg/dl) 48.2 1.8
Body mass index 27.7 0.5
Statin treatment 63Values are mean  SEM or %.
HDL  high-density lipoprotein; LDL  low-density lipoprotein.
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atherosclerosis.
The link between PD and atherosclerosis has been well
documented previously. Previous imaging studies have also
reported an association between PD and carotid atherosclerosis
per se (6,32,33). Soder et al. (6) showed that patients with PD
have greater mean values of common carotid artery intima-
media thickness and intima-media area than those without
significant PD, implying a connection between PD and the
growth of early atherosclerotic lesions in the carotid. Desvarieux
et al. (33) showed a relationship between periodontal disease,
tooth loss, and carotid artery plaque. ICARAS (Inflammation
and Carotid Artery–Risk for Atherosclerosis Study) (34) dem-
onstrated that the presence of PD was associated with progres-
sion of carotid atherosclerosis over the subsequent year. Our
study is, to our knowledge, the first to directly correlate PD
with atherosclerotic plaque inflammation as assessed both by
FDG-PET and by histological examination.
In our study, we used PET imaging to quantify the
metabolic activity of gingival tissues. Clinically, periodontal
FDG uptake has been used to evaluate for the presence of
oral tumors (26,27). It has been previously established that
the majority of FDG uptake associated with tumors is
attributable to inflammatory tissues, primarily macrophages
(35,36). Here, we propose that, similar to what is seen in
atherosclerotic plaque (11,25,30,37,38), FDG uptake in
periodontal tissue is the result of pathological processes. It is
likely that this excess FDG uptake is related to PD-
associated inflammatory cell content. It is also possible that
periodontal FDG uptake is in part the result of bacterial
consumption of FDG.
The mechanisms linking PD and atherosclerosis are not
Figure 2 Periodontal FDG Uptake Versus Carotid FDG Uptake
In 112 patients, 18F-fluorodeoxyglucose (FDG) uptake (target-to-background
ratio [TBR]) within periodontal tissues was compared with FDG uptake in the
carotid arteries of the same patients. A significant relationship was observed
between periodontal TBR and carotid artery TBR.fully elucidated but appear to be multifaceted. A possibleatherogenic role for periodontal pathogens might be sug-
gested as one mechanism. Bacterial DNA from several
organisms has been discovered in samples taken from
endarterectomy and may contribute to the process of plaque
inflammation (3,4,7,39–41). Furthermore, gingival bacteria
have been implicated in several mechanisms that lead to
increased atherosclerotic plaque inflammation, including
induction of foam cells (42), stimulation of phagocytic
nicotinamide adenine dinucleotide phosphate oxidase and
matrix metallopeptidase-9 (43), and endothelial cell dys-
function (44).
Although no conclusions about a potential causal relation-
ship between periodontal disease and vascular inflammation
can be drawn from our current study, prior observations leave
it as a possibility. Findings from a recent study demonstrated a
reduction of carotid intima-media thickness as a result of
periodontal treatment (45). Along similar lines, others have
shown that improving oral health can reduce both the local and
systemic markers of inflammation (46,47) and improve endo-
thelial function (48,49). Future studies should be conducted to
verify and quantify these relationships.
Our findings contribute to the growing literature linking PD
and atherosclerosis by producing coincidental observations of
carotid plaque inflammation with PET measures of PD.
Although we do not believe that PET measures of PD will
provide valuable information for risk stratification, we do
propose that the findings of this study may set the stage for
future investigations regarding the effect of treatment of PD on
carotid plaque inflammation. In such a study, PET could be
used to test the hypothesis that intensive periodontal treatment
and the reduction of oral inflammation could lead to reduction
of carotid plaque inflammation. Such a finding, if confirmed,
could have important clinical implications and would under-
score a role for intensified oral hygiene as an important
component of treatment of patients with atherosclerotic
disease.
Study limitations. Although our study demonstrates a
significant relationship between the inflammatory status of
carotid atherosclerotic plaques and periodontal tissue, it has
several limitations. We performed a cross-sectional analysis
that was not primarily designed to examine the relationship
between FDG uptake in periodontal tissue and FDG
uptake in the carotid and aorta as well as inflammation in
macrophage-rich carotid atherosclerotic plaques. The re-
sults of this study need to be further validated in prospective,
large-scale FDG-PET trials examining indices of periodon-
tal activity as possible predictors of atherosclerotic plaque
inflammation.
Conclusions
Our study finds that the FDG signal in periodontal tissues is
correlated with carotid atherosclerotic disease assessed both by
FDG-PET and by histological examination, further strengthen-
975JACC Vol. 57, No. 8, 2011 Fifer et al.
February 22, 2011:971–6 Periodontal FDG Uptake and Carotid Inflammationing the connection between periodontal disease and atherosclero-
sis. This finding has potentially important clinical implications
and, if supported by larger validation trials, may highlight PD as a
potentially modifiable risk factor for atherosclerotic disease.
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Trichrome and CD68 staining were performed on atherosclerotic plaques that were
patient with relatively low periodontal 18F-fluorodeoxyglucose (FDG) uptake and sho
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